An unclear role for the GLP-1 metabolite GLP-1(9-36) in human islet physiology

被引：2
作者：
Matveyenko, Aleksey [1 ]
Vella, Adrian [2 ]
机构：
[1] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA
[2] Mayo Clin, Coll Med, Div Endocrinol Diabet & Metab, Rochester, MN 55905 USA
来源：
DIABETOLOGIA | 2024年 / 67卷 / 07期
基金：
美国国家卫生研究院;
关键词：
Alpha cell function; Beta cell function; Dipeptidyl peptidase 4; Endogenous glucose production; Glucagon-like peptide 1; Glucagon suppression; Insulin secretion; GLUCAGON;
D O I：
10.1007/s00125-024-06141-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1444 / 1445
页数：2
相关论文
共 50 条
  • [31] GLP-1 as a target for therapeutic intervention
    Rajeev, Surya Panicker
    Wilding, John
    CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 44 - 49
  • [32] Regulation of Adipocyte Formation by GLP-1/GLP-1R Signaling
    Challa, Tenagne Delessa
    Beaton, Nigel
    Arnold, Myrtha
    Rudofsky, Gottfried
    Langhans, Wolfgang
    Wolfrum, Christian
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (09) : 6421 - 6430
  • [33] A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
    Marchetti, P.
    Lupi, R.
    Bugliani, M.
    Kirkpatrick, C. L.
    Sebastiani, G.
    Grieco, F. A.
    Del Guerra, S.
    D'Aleo, V.
    Piro, S.
    Marselli, L.
    Boggi, U.
    Filipponi, F.
    Tinti, L.
    Salvini, L.
    Wollheim, C. B.
    Purrello, F.
    Dotta, F.
    DIABETOLOGIA, 2012, 55 (12) : 3262 - 3272
  • [34] Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
    Flint, Anne
    Nazzal, Khalil
    Jagielski, Pawel
    Hindsberger, Charlotte
    Zdravkovic, Milan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (06) : 807 - 814
  • [35] Effects of tryptophan-selective lipidated glucagon-like peptide 1 (GLP-1) peptides on the GLP-1 receptor
    Lu, Xuejing
    Harada, Norio
    Yasuda, Takuma
    Ikeguchi-Ogura, Eri
    Kobayashi, Daishiro
    Denda, Masaya
    Seno, Yohei
    Yamane, Shunsuke
    Yabe, Daisuke
    Otaka, Akira
    Inagaki, Nobuya
    JOURNAL OF ENDOCRINOLOGY, 2025, 264 (03)
  • [36] Intra-islet GLP-1, but not CCK, is necessary for β-cell function in mouse and human islets
    de Souza, Arnaldo Henrique
    Tang, Jiayin
    Yadev, Amanjot Kaur
    Saghafi, Samuel T.
    Kibbe, Carly R.
    Linnemann, Amelia K.
    Merrins, Matthew J.
    Davis, Dawn Belt
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
    Aulinger, Benedikt A.
    Bedorf, Anne
    Kutscherauer, Gabriele
    de Heer, Jocelyn
    Holst, Jens J.
    Goeke, Burkhard
    Schirra, Joerg
    DIABETES, 2014, 63 (03) : 1079 - 1092
  • [38] Possible Role of GLP-1 and Its Agonists in the Treatment of Type 1 Diabetes Mellitus
    Issa, Claire M.
    Azar, Sami T.
    CURRENT DIABETES REPORTS, 2012, 12 (05) : 560 - 567
  • [39] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [40] GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
    Li, Ying
    Zheng, Xuemin
    Tang, Lida
    Xu, Weiren
    Gong, Min
    PEPTIDES, 2011, 32 (06) : 1303 - 1312
12345